[144] Workday, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 notice filed for Workday, Inc. (WDAY) reports a proposed sale of 78,564 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $17,500,131.00. The filing states the shares were acquired in a private placement on 12/27/2007 and paid for in cash. The issuer has 217,000,000 shares outstanding, and the approximate date of sale is 09/16/2025 on NASDAQ. The filing also discloses multiple recent 10b5-1 program sales by related trusts and a foundation between 06/17/2025 and 09/15/2025, including transactions of 15,000 to 75,817 shares with gross proceeds reported.
Positive
- Full regulatory disclosure provided including broker, acquisition date, and payment method
- Sale size is small relative to outstanding shares (78,564 of 217,000,000)
Negative
- Insider-related sales (trusts and foundation) could be viewed unfavorably by some investors despite being programmatic
- Multiple recent dispositions under 10b5-1 plans indicate ongoing supply of shares to market
Insights
TL;DR Insider-related planned sale disclosed; size is small relative to outstanding shares and follows prior scheduled 10b5-1 sales.
The Form 144 provides standard regulatory notice of a proposed sale of 78,564 Workday common shares via Morgan Stanley Smith Barney. The shares were originally acquired in a private placement in 2007 with cash payment. The filing lists multiple 10b5-1 program sales by affiliated trusts and a foundation in mid-2025, showing ongoing systematic dispositions. On a relative basis (78,564 versus 217 million shares outstanding), the proposed sale represents a de minimis ownership change and is consistent with previously disclosed programmatic sales.
TL;DR Disclosure is complete for Rule 144 purposes; recurring 10b5-1 activity is noted but not shown as materially dilutive.
The filing meets Rule 144 disclosure requirements by identifying the broker, acquisition history, and intended sale date. It documents that the securities were acquired in a private placement and that payment was in cash. The record of recent 10b5-1 sales by The David A Duffield Trust and The Dave & Cheryl Duffield Foundation indicates established trading plans or instructions. There is no indication of undisclosed material non-public information in this notice.